F&FFinancial Insights

Financial Metrics

SRPT Sarepta Therapeutics, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 27 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2017-03-31 16342000.0 USD 10-Q 2018-05-03
Quarterly 2017-06-30 35011000.0 +114.2% USD 10-Q 2018-08-08
Quarterly 2017-09-30 45954000.0 +31.3% USD 10-Q 2018-10-31
Quarterly 2018-03-31 64604000.0 +40.6% USD 10-Q 2019-05-08
Quarterly 2018-06-30 73529000.0 +13.8% USD 10-Q 2019-08-07
Quarterly 2018-09-30 78486000.0 +6.7% USD 10-Q 2019-11-07
Quarterly 2019-03-31 87011000.0 +10.9% USD 10-Q 2020-05-06
Quarterly 2019-06-30 94668000.0 +8.8% USD 10-Q 2020-08-05
Quarterly 2019-09-30 99041000.0 +4.6% USD 10-Q 2020-11-05
Quarterly 2020-03-31 113674000.0 +14.8% USD 10-Q 2021-05-05
Quarterly 2020-06-30 137363000.0 +20.8% USD 10-Q 2021-08-04
Quarterly 2020-09-30 143924000.0 +4.8% USD 10-Q 2021-11-03
Quarterly 2021-03-31 146931000.0 +2.1% USD 10-Q 2022-05-04
Quarterly 2021-06-30 164089000.0 +11.7% USD 10-Q 2022-08-02
Quarterly 2021-09-30 189406000.0 +15.4% USD 10-Q 2022-11-02
Quarterly 2022-03-31 210830000.0 +11.3% USD 10-Q 2023-05-02
Quarterly 2022-06-30 233487000.0 +10.7% USD 10-Q 2023-08-02
Quarterly 2022-09-30 230269000.0 -1.4% USD 10-Q 2023-11-01
Quarterly 2023-03-31 253500000.0 +10.1% USD 10-Q 2024-05-01
Quarterly 2023-06-30 261238000.0 +3.1% USD 10-Q 2024-08-07
Quarterly 2023-09-30 331817000.0 +27.0% USD 10-Q 2024-11-06
Quarterly 2024-03-31 413464000.0 +24.6% USD 10-Q 2025-05-06
Quarterly 2024-06-30 362931000.0 -12.2% USD 10-Q 2025-08-06
Quarterly 2024-09-30 467172000.0 +28.7% USD 10-Q 2025-11-06
Quarterly 2025-03-31 744856000.0 +59.4% USD 10-Q 2025-05-06
Quarterly 2025-06-30 611091000.0 -18.0% USD 10-Q 2025-08-06
Quarterly 2025-09-30 399356000.0 -34.6% USD 10-Q 2025-11-06
Annual 2016-12-31 5421000.0 USD 10-K 2019-02-28
Annual 2017-12-31 154584000.0 +2751.6% USD 10-K 2020-02-26
Annual 2018-12-31 301034000.0 +94.7% USD 10-K 2021-03-01
Annual 2019-12-31 380833000.0 +26.5% USD 10-K 2022-03-01
Annual 2020-12-31 540099000.0 +41.8% USD 10-K 2023-02-28
Annual 2021-12-31 701887000.0 +30.0% USD 10-K 2024-02-28
Annual 2022-12-31 933013000.0 +32.9% USD 10-K 2025-02-28
Annual 2023-12-31 1243336000.0 +33.3% USD 10-K 2026-03-02
Annual 2024-12-31 658412000.0 -47.0% USD 10-K 2026-03-02
Annual 2025-12-31 442934000.0 -32.7% USD 10-K 2026-03-02

Gross Profit

Q: 0 | A: 2

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2024-12-31 505853000.0 USD 10-K 2026-03-02
Annual 2025-12-31 -29101000.0 -105.8% USD 10-K 2026-03-02

Operating Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -59702000.0 USD 10-Q 2017-05-04
Quarterly 2016-06-30 -62100000.0 -4.0% USD 10-Q 2017-08-03
Quarterly 2016-09-30 -56533000.0 +9.0% USD 10-Q 2017-11-01
Quarterly 2017-03-31 -39245000.0 +30.6% USD 10-Q 2018-05-03
Quarterly 2017-06-30 -63339000.0 -61.4% USD 10-Q 2018-08-08
Quarterly 2017-09-30 -45907000.0 +27.5% USD 10-Q 2018-10-31
Quarterly 2018-03-31 -30739000.0 +33.0% USD 10-Q 2019-05-08
Quarterly 2018-06-30 -103427000.0 -236.5% USD 10-Q 2019-08-07
Quarterly 2018-09-30 -70099000.0 +32.2% USD 10-Q 2019-11-07
Quarterly 2019-03-31 -76387000.0 -9.0% USD 10-Q 2020-05-06
Quarterly 2019-06-30 -275367000.0 -260.5% USD 10-Q 2020-08-05
Quarterly 2019-09-30 -123590000.0 +55.1% USD 10-Q 2020-11-05
Quarterly 2020-03-31 -118026000.0 +4.5% USD 10-Q 2021-05-05
Quarterly 2020-06-30 -138353000.0 -17.2% USD 10-Q 2021-08-04
Quarterly 2020-09-30 -137068000.0 +0.9% USD 10-Q 2021-11-03
Quarterly 2021-03-31 -151865000.0 -10.8% USD 10-Q 2022-05-04
Quarterly 2021-06-30 -167574000.0 -10.3% USD 10-Q 2022-08-02
Quarterly 2021-09-30 -34458000.0 +79.4% USD 10-Q 2022-11-02
Quarterly 2022-03-31 -86881000.0 -152.1% USD 10-Q 2023-05-02
Quarterly 2022-06-30 -211132000.0 -143.0% USD 10-Q 2023-08-02
Quarterly 2022-09-30 -131355000.0 +37.8% USD 10-Q 2023-11-01
Quarterly 2023-03-31 -138088000.0 -5.1% USD 10-Q 2024-05-01
Quarterly 2023-06-30 -133519000.0 +3.3% USD 10-Q 2024-08-07
Quarterly 2023-09-30 -20842000.0 +84.4% USD 10-Q 2024-11-06
Quarterly 2024-03-31 34905000.0 +267.5% USD 10-Q 2025-05-06
Quarterly 2024-06-30 -701000.0 -102.0% USD 10-Q 2025-08-06
Quarterly 2024-09-30 22196000.0 +3266.3% USD 10-Q 2025-11-06
Quarterly 2025-03-31 -300386000.0 -1453.3% USD 10-Q 2025-05-06
Quarterly 2025-06-30 115577000.0 +138.5% USD 10-Q 2025-08-06
Quarterly 2025-09-30 -103389000.0 -189.5% USD 10-Q 2025-11-06
Annual 2016-12-31 -266730000.0 USD 10-K 2019-02-28
Annual 2017-12-31 -171638000.0 +35.7% USD 10-K 2020-02-26
Annual 2018-12-31 -343628000.0 -100.2% USD 10-K 2021-03-01
Annual 2019-12-31 -705563000.0 -105.3% USD 10-K 2022-03-01
Annual 2020-12-31 -564163000.0 +20.0% USD 10-K 2023-02-28
Annual 2021-12-31 -459710000.0 +18.5% USD 10-K 2024-02-28
Annual 2022-12-31 -536201000.0 -16.6% USD 10-K 2025-02-28
Annual 2023-12-31 -267824000.0 +50.1% USD 10-K 2026-03-02
Annual 2024-12-31 218081000.0 +181.4% USD 10-K 2026-03-02
Annual 2025-12-31 -699781000.0 -420.9% USD 10-K 2026-03-02

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -59770000.0 USD 10-Q 2017-05-04
Quarterly 2016-06-30 -62301000.0 -4.2% USD 10-Q 2017-08-03
Quarterly 2016-09-30 -56742000.0 +8.9% USD 10-Q 2017-11-01
Quarterly 2017-03-31 84090000.0 +248.2% USD 10-Q 2018-05-03
Quarterly 2017-06-30 21044000.0 -75.0% USD 10-Q 2018-08-08
Quarterly 2017-09-30 -26690000.0 -226.8% USD 10-Q 2018-10-31
Quarterly 2018-03-31 -35363000.0 -32.5% USD 10-Q 2019-11-07
Quarterly 2018-06-30 -109267000.0 -209.0% USD 10-Q 2019-11-07
Quarterly 2018-09-30 -221023000.0 -102.3% USD 10-Q 2019-11-07
Quarterly 2019-03-31 -76643000.0 +65.3% USD 10-Q 2020-11-05
Quarterly 2019-06-30 -276403000.0 -260.6% USD 10-Q 2020-11-05
Quarterly 2019-09-30 -479372000.0 -73.4% USD 10-Q 2020-11-05
Quarterly 2020-03-31 -17492000.0 +96.4% USD 10-Q 2021-11-03
Quarterly 2020-06-30 -150820000.0 -762.2% USD 10-Q 2021-11-03
Quarterly 2020-09-30 -364811000.0 -141.9% USD 10-Q 2021-11-03
Quarterly 2021-03-31 -167250000.0 +54.2% USD 10-Q 2022-11-02
Quarterly 2021-06-30 -81405000.0 +51.3% USD 10-Q 2022-11-02
Quarterly 2021-09-30 -296799000.0 -264.6% USD 10-Q 2022-11-02
Quarterly 2022-03-31 -105025000.0 +64.6% USD 10-Q 2023-11-01
Quarterly 2022-06-30 -231481000.0 -120.4% USD 10-Q 2023-11-01
Quarterly 2022-09-30 -594244000.0 -156.7% USD 10-Q 2023-11-01
Quarterly 2023-03-31 -516755000.0 +13.0% USD 10-Q 2024-11-06
Quarterly 2023-06-30 -23940000.0 +95.4% USD 10-Q 2024-11-06
Quarterly 2023-09-30 -581632000.0 -2329.5% USD 10-Q 2024-11-06
Quarterly 2024-03-31 36119000.0 +106.2% USD 10-Q 2025-11-06
Quarterly 2024-06-30 6460000.0 -82.1% USD 10-Q 2025-11-06
Quarterly 2024-09-30 76190000.0 +1079.4% USD 10-Q 2025-11-06
Quarterly 2025-03-31 -447508000.0 -687.4% USD 10-Q 2025-11-06
Quarterly 2025-06-30 196892000.0 +144.0% USD 10-Q 2025-11-06
Quarterly 2025-09-30 -430563000.0 -318.7% USD 10-Q 2025-11-06
Annual 2016-12-31 -267265000.0 USD 10-K 2019-02-28
Annual 2017-12-31 -50688000.0 +81.0% USD 10-K 2020-02-26
Annual 2018-12-31 -361918000.0 -614.0% USD 10-K 2021-03-01
Annual 2019-12-31 -715075000.0 -97.6% USD 10-K 2022-03-01
Annual 2020-12-31 -554128000.0 +22.5% USD 10-K 2023-02-28
Annual 2021-12-31 -418780000.0 +24.4% USD 10-K 2024-02-28
Annual 2022-12-31 -703488000.0 -68.0% USD 10-K 2025-02-28
Annual 2023-12-31 -535977000.0 +23.8% USD 10-K 2026-03-02
Annual 2024-12-31 235239000.0 +143.9% USD 10-K 2026-03-02
Annual 2025-12-31 -713410000.0 -403.3% USD 10-K 2026-03-02

EPS Basic

Q: 20 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -1.31 USD/shares 10-Q 2017-05-04
Quarterly 2016-06-30 -1.35 -3.1% USD/shares 10-Q 2017-08-03
Quarterly 2017-03-31 1.53 +213.3% USD/shares 10-Q 2018-05-03
Quarterly 2017-06-30 -1.15 -175.2% USD/shares 10-Q 2018-08-08
Quarterly 2018-03-31 -0.55 +52.2% USD/shares 10-Q 2018-05-03
Quarterly 2018-06-30 -1.67 -203.6% USD/shares 10-Q 2018-08-08
Quarterly 2021-06-30 -1.02 +38.9% USD/shares 10-Q 2022-08-02
Quarterly 2021-09-30 -0.6 +41.2% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 -1.2 -100.0% USD/shares 10-Q 2023-05-02
Quarterly 2022-06-30 -2.65 -120.8% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 -2.94 -10.9% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 -5.86 -99.3% USD/shares 10-Q 2024-05-01
Quarterly 2023-06-30 -0.27 +95.4% USD/shares 10-Q 2024-08-07
Quarterly 2023-09-30 -0.46 -70.4% USD/shares 10-Q 2024-11-06
Quarterly 2024-03-31 0.38 +182.6% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 0.07 -81.6% USD/shares 10-Q 2025-08-06
Quarterly 2024-09-30 0.35 +400.0% USD/shares 10-Q 2025-11-06
Quarterly 2025-03-31 -4.6 -1414.3% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 2.01 +143.7% USD/shares 10-Q 2025-08-06
Quarterly 2025-09-30 -1.8 -189.6% USD/shares 10-Q 2025-11-06
Annual 2017-12-31 -0.37 USD/shares 10-K 2019-02-28
Annual 2020-12-31 -7.11 -1821.6% USD/shares 10-K 2023-02-28
Annual 2021-12-31 -5.15 +27.6% USD/shares 10-K 2024-02-28
Annual 2022-12-31 -8.03 -55.9% USD/shares 10-K 2025-02-28
Annual 2023-12-31 -5.8 +27.8% USD/shares 10-K 2026-03-02
Annual 2024-12-31 1.65 +128.4% USD/shares 10-K 2026-03-02
Annual 2025-12-31 -3.93 -338.2% USD/shares 10-K 2026-03-02

EPS Diluted

Q: 20 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -1.31 USD/shares 10-Q 2017-05-04
Quarterly 2016-06-30 -1.35 -3.1% USD/shares 10-Q 2017-08-03
Quarterly 2017-03-31 1.5 +211.1% USD/shares 10-Q 2018-05-03
Quarterly 2017-06-30 -1.15 -176.7% USD/shares 10-Q 2018-08-08
Quarterly 2018-03-31 -0.55 +52.2% USD/shares 10-Q 2018-05-03
Quarterly 2018-06-30 -1.67 -203.6% USD/shares 10-Q 2018-08-08
Quarterly 2021-06-30 -1.02 +38.9% USD/shares 10-Q 2022-08-02
Quarterly 2021-09-30 -0.6 +41.2% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 -1.2 -100.0% USD/shares 10-Q 2023-05-02
Quarterly 2022-06-30 -2.65 -120.8% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 -2.94 -10.9% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 -5.86 -99.3% USD/shares 10-Q 2024-05-01
Quarterly 2023-06-30 -0.27 +95.4% USD/shares 10-Q 2024-08-07
Quarterly 2023-09-30 -0.46 -70.4% USD/shares 10-Q 2024-11-06
Quarterly 2024-03-31 0.37 +180.4% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 0.07 -81.1% USD/shares 10-Q 2025-08-06
Quarterly 2024-09-30 0.34 +385.7% USD/shares 10-Q 2025-11-06
Quarterly 2025-03-31 -4.6 -1452.9% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 1.89 +141.1% USD/shares 10-Q 2025-08-06
Quarterly 2025-09-30 -1.8 -195.2% USD/shares 10-Q 2025-11-06
Annual 2017-12-31 -0.37 USD/shares 10-K 2019-02-28
Annual 2020-12-31 -7.11 -1821.6% USD/shares 10-K 2023-02-28
Annual 2021-12-31 -5.15 +27.6% USD/shares 10-K 2024-02-28
Annual 2022-12-31 -8.03 -55.9% USD/shares 10-K 2025-02-28
Annual 2023-12-31 -5.8 +27.8% USD/shares 10-K 2026-03-02
Annual 2024-12-31 1.5 +125.9% USD/shares 10-K 2026-03-02
Annual 2025-12-31 -3.93 -362.0% USD/shares 10-K 2026-03-02

8-K Material Event Details

38 filings · 90 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

422 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-12 Mayo Stephen Open-market sell
S
Common Stock 7,239 $17.02 $123,208 1,765
2026-03-11 Estepan Ian Michael Chief Operating Officer Other disposed transaction
F
Common Stock 1,097 $17.03 $18,682 201,983
2026-03-09 Wong Ryan Ho-Yan Chief Financial Officer Other disposed transaction
F
Common Stock 113 $16.95 $1,915 135,320
2026-03-09 Wong Ryan Ho-Yan Chief Financial Officer Other disposed transaction
F
Common Stock 162 $16.95 $2,746 135,433
2026-03-02 Estepan Ian Michael Chief Operating Officer Other disposed transaction
F
Common Stock 875 $16.20 $14,175 204,699
2026-03-02 Estepan Ian Michael Chief Operating Officer Other disposed transaction
F
Common Stock 3,301 $16.20 $53,476 205,574
2026-03-02 Rothfuss Cristin EVP, General Counsel Other disposed transaction
F
Common Stock 408 $16.20 $6,610 139,348
2026-03-01 Estepan Ian Michael Chief Operating Officer Exercise / conversion
M · derivative
Performance Stock Units 8,125 $0.00 $0 0
2026-03-01 Estepan Ian Michael Chief Operating Officer Exercise / conversion
M
Common Stock 8,125 208,875
2026-02-26 Estepan Ian Michael Chief Operating Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 5,381 $0.00 $0 0
2026-02-26 Estepan Ian Michael Chief Operating Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 2,069 $0.00 $0 0
2026-02-26 Estepan Ian Michael Chief Operating Officer Exercise / conversion
M
Common Stock 5,381 $13.71 $73,774 200,750
2026-02-26 Estepan Ian Michael Chief Operating Officer Exercise / conversion
M
Common Stock 2,069 $13.71 $28,366 195,369
2026-02-25 Estepan Ian Michael Chief Operating Officer Equity grant / award
A · derivative
Performance Stock Units 1,875 8,125
2026-01-29 Nicaise Claude Exercise / conversion
M · derivative
Stock Option (right to buy) 10,500 $0.00 $0 0
2026-01-29 Nicaise Claude Other disposed transaction
F
Common Stock 6,780 $21.23 $143,939 31,532
2026-01-29 Nicaise Claude Exercise / conversion
M
Common Stock 10,500 $13.71 $143,955 38,312
2026-01-27 BEHRENS M KATHLEEN Exercise / conversion
M · derivative
Stock Option (right to buy) 10,500 $0.00 $0 0
2026-01-27 BEHRENS M KATHLEEN Other disposed transaction
F
Common Stock 6,494 $22.17 $143,972 197,482
2026-01-27 BEHRENS M KATHLEEN Exercise / conversion
M
Common Stock 10,500 $13.71 $143,955 203,976
2025-12-18 Chambers Michael Andrew Equity grant / award
A · derivative
Convertible Senior Notes
2025-12-18 Chambers Michael Andrew Other disposed transaction
D · derivative
Convertible Senior Notes
2025-12-16 Estepan Ian Michael Chief Operating Officer Open-market sell
S
Common Stock 13,187 $22.31 $294,202 193,300
2025-12-07 INGRAM DOUGLAS S Chief Executive Officer Equity grant / award
A
Common Stock 269,542 $0.00 $0 929,391
2025-12-07 INGRAM DOUGLAS S Chief Executive Officer Equity grant / award
A
Common Stock 96,541 $0.00 $0 659,849
2025-12-07 INGRAM DOUGLAS S Chief Executive Officer Equity grant / award
A
Common Stock 73,001 $0.00 $0 563,308
2025-12-07 INGRAM DOUGLAS S Chief Executive Officer Equity grant / award
A
Common Stock 50,000 $0.00 $0 490,307
2025-12-01 Wong Ryan Ho-Yan Chief Financial Officer Other disposed transaction
F
Common Stock 78 $20.96 $1,635 136,045
2025-12-01 Wong Ryan Ho-Yan Chief Financial Officer Other disposed transaction
F
Common Stock 80 $20.96 $1,677 136,123
2025-11-28 Rothfuss Cristin EVP, General Counsel Other disposed transaction
F
Common Stock 229 $21.12 $4,836 139,756
2025-11-17 Rodino-Klapac Louise President, R&D and Tech Ops Other disposed transaction
F
Common Stock 4,582 $18.42 $84,400 224,030
2025-09-03 Rodino-Klapac Louise President, R&D and Tech Ops Equity grant / award
A
Common Stock 50,000 $0.00 $0 228,612
2025-09-03 Rodino-Klapac Louise President, R&D and Tech Ops Equity grant / award
A
Common Stock 93,875 $0.00 $0 178,612
2025-08-05 Arif Bilal Chief Tech Ops Officer Equity grant / award
A · derivative
Performance Stock Units 6,250 $0.00 $0 6,250
2025-07-31 Wong Ryan Ho-Yan Chief Financial Officer Other disposed transaction
F
Common Stock 327 $16.42 $5,369 17,328
2025-05-16 Barry Richard Exercise / conversion
M · derivative
Stock Option (right to buy) 12,350 $0.00 $0 0
2025-05-16 Barry Richard Exercise / conversion
M
Common Stock 12,350 $32.63 $402,980 2,966,667
2025-05-13 Barry Richard Exercise / conversion
M · derivative
Stock Option (right to buy) 10,500 $0.00 $0 0
2025-05-13 Barry Richard Exercise / conversion
M · derivative
Stock Option (right to buy) 9,746 $0.00 $0 0
2025-05-13 Barry Richard Exercise / conversion
M
Common Stock 10,500 $13.71 $143,955 2,954,317
2025-05-13 Barry Richard Exercise / conversion
M
Common Stock 9,746 $25.18 $245,404 2,943,817
2025-03-12 Nicaise Claude Exercise / conversion
M · derivative
Stock Options (right to buy) 9,746 $0.00 $0 0
2025-03-12 Nicaise Claude Open-market sell
S
Common Stock 2,491 $99.64 $248,203 27,812
2025-03-12 Nicaise Claude Exercise / conversion
M
Common Stock 9,746 $25.18 $245,404 30,303
2025-03-10 Estepan Ian Michael Chief Financial Officer Equity grant / award
A · derivative
Stock Options (right to buy) 16,644 $0.00 $0 16,644
2025-03-10 Estepan Ian Michael Chief Financial Officer Equity grant / award
A
Common Stock 8,276 62,612
2025-03-10 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 2,890 $100.13 $289,376 54,336
2025-03-10 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 1,051 $100.13 $105,237 57,226
2025-03-10 Connelly Deirdre P Equity grant / award
A · derivative
Stock Options (right to buy) 4,792 $0.00 $0 4,792
2025-03-10 Connelly Deirdre P Equity grant / award
A
Common Stock 2,383 5,225
2025-03-07 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 9,094 $103.70 $943,048 52,777
2025-03-07 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 585 $103.70 $60,664 61,871
2025-03-07 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M · derivative
Performance Stock Units 5,500 $0.00 $0 0
2025-03-07 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M
Common Stock 5,500 58,277
2025-03-06 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M · derivative
Performance Stock Units 17,500 $0.00 $0 0
2025-03-06 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M
Common Stock 17,500 62,456
2025-03-04 Rothfuss Cristin EVP, General Counsel Other disposed transaction
F
Common Stock 296 $101.34 $29,997 13,325
2025-03-04 Rothfuss Cristin EVP, General Counsel Other disposed transaction
F
Common Stock 288 $101.34 $29,186 13,037
2025-03-03 Murray Dallan Chief Customer Officer Other disposed transaction
F
Common Stock 711 $103.77 $73,780 21,506
2025-02-11 Estepan Ian Michael Chief Financial Officer Equity grant / award
A · derivative
Performance Restricted Stock Units 3,500 $0.00 $0 17,500
2025-01-29 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 1,533 $0.00 $0 0
2025-01-29 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 14,267 $0.00 $0 0
2025-01-29 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 2,613 $117.51 $307,054 46,883
2025-01-29 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M
Common Stock 1,533 $12.00 $18,396 49,496
2025-01-29 Estepan Ian Michael Chief Financial Officer Exercise / conversion
M
Common Stock 14,267 $12.00 $171,204 47,963
2024-12-27 Estepan Ian Michael Chief Financial Officer Equity grant / award
G
Common Stock 250 $0.00 $0 33,696
2024-12-12 Wigzell Hans Lennart Rudolf Exercise / conversion
M · derivative
Stock Options (right to buy) 10,500 $0.00 $0 0
2024-12-12 Wigzell Hans Lennart Rudolf Open-market sell
S
Common Stock 10,500 $124.84 $1,310,820 22,840
2024-12-12 Wigzell Hans Lennart Rudolf Exercise / conversion
M
Common Stock 10,500 $13.71 $143,955 33,340
2024-12-05 Boor Kathryn Jean Open-market sell
S
Common Stock 1,636 $125.55 $205,400 5,880
2024-11-26 Rothfuss Cristin EVP, General Counsel Equity grant / award
A · derivative
Stock Option (right to buy) 4,000 $0.00 $0 4,000
2024-11-26 Rothfuss Cristin EVP, General Counsel Equity grant / award
A
Common Stock 2,000 $0.00 $0 13,817
2024-11-18 Rodino-Klapac Louise Head of R&D, CSO Other disposed transaction
F
Common Stock 4,558 $102.89 $468,973 67,630
2024-09-12 Connelly Deirdre P Equity grant / award
A · derivative
Stock Option (right to buy) 6,442 $0.00 $0 6,442
2024-09-12 Connelly Deirdre P Equity grant / award
A
Common Stock 2,842 $0.00 $0 2,842
2024-09-04 BEHRENS M KATHLEEN Equity grant / award
G
Common Stock 746 $0.00 $0 191,093
2024-08-30 Estepan Ian Michael Chief Financial Officer Open-market sell
S
Common Stock 5,985 $137.36 $822,100 33,946
2024-08-16 Chambers Michael Andrew Open-market buy
P
Common Stock 5,648 $134.66 $760,560 284,034
2024-08-16 Chambers Michael Andrew Open-market buy
P
Common Stock 18,284 $134.06 $2,451,153 278,386
2024-08-16 Chambers Michael Andrew Open-market buy
P
Common Stock 13,106 $133.07 $1,744,015 260,102
2024-07-03 BEHRENS M KATHLEEN Exercise / conversion
M · derivative
Stock Option (right to buy) 15,000 $0.00 $0 0
2024-07-03 BEHRENS M KATHLEEN Exercise / conversion
M
Common Stock 15,000 $13.90 $208,500 191,839
2024-06-25 Brown Ryan Edward EVP, General Counsel Exercise / conversion
M · derivative
Stock Option (right to buy) 23,500 $0.00 $0 0
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 2,549 $164.52 $419,361 17,129
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 3,840 $163.53 $627,955 19,678
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 17,581 $162.65 $2,859,550 23,518
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 4,168 $161.82 $674,466 41,099
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 975 $160.31 $156,302 45,267
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 2,200 $159.14 $350,108 46,242
2024-06-25 Brown Ryan Edward EVP, General Counsel Open-market sell
S
Common Stock 7,644 $158.07 $1,208,287 48,442
2024-06-25 Brown Ryan Edward EVP, General Counsel Exercise / conversion
M
Common Stock 23,500 $62.77 $1,475,095 56,086
2024-06-24 Brown Ryan Edward EVP, General Counsel Other disposed transaction
F
Common Stock 2,352 $164.64 $387,233 32,586
2024-06-21 Brown Ryan Edward EVP, General Counsel Exercise / conversion
M · derivative
Performance Stock Units 6,250 $0.00 $0 0
2024-06-21 Brown Ryan Edward EVP, General Counsel Equity grant / award
A · derivative
Performance Stock Units 6,250 $0.00 $0 6,250
2024-06-21 Brown Ryan Edward EVP, General Counsel Equity grant / award
A · derivative
Performance Stock Units 5,500 $0.00 $0 5,500
2024-06-21 Brown Ryan Edward EVP, General Counsel Exercise / conversion
M
Common Stock 6,250 34,938
2024-05-02 Murray Dallan Chief Customer Officer Open-market sell
S
Common Stock 3,635 $140.00 $508,900 18,125
2024-03-11 Boor Kathryn Jean Open-market sell
S
Common Stock 761 $122.93 $93,550 7,516
2024-03-08 Arif Bilal Chief Tech Ops Officer Other disposed transaction
F
Common Stock 472 $123.14 $58,122 25,222
2024-03-08 Wigzell Hans Lennart Rudolf Exercise / conversion
M · derivative
Stock Option (right to buy) 15,000 $0.00 $0 0
2024-03-08 Wigzell Hans Lennart Rudolf Open-market sell
S
Common Stock 100 $122.39 $12,239 22,840
2024-03-08 Wigzell Hans Lennart Rudolf Open-market sell
S
Common Stock 11,745 $123.10 $1,445,810 22,940
2024-03-08 Wigzell Hans Lennart Rudolf Open-market sell
S
Common Stock 3,155 $123.85 $390,747 34,685
2024-03-08 Wigzell Hans Lennart Rudolf Exercise / conversion
M
Common Stock 15,000 $13.90 $208,500 37,840
2024-03-07 Arif Bilal Chief Tech Ops Officer Other disposed transaction
F
Common Stock 506 $120.49 $60,968 25,694
2024-03-05 Mayo Stephen Open-market sell
S
Common Stock 3,135 $122.96 $385,480 6,621
2024-03-04 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 1,389 $125.32 $174,069 37,725
2024-03-01 Nicaise Claude Equity grant / award
A · derivative
Stock Option (right to buy) 3,679 $0.00 $0 3,679
2024-03-01 Nicaise Claude Equity grant / award
A
Common Stock 1,846 $0.00 $0 18,174
2023-12-01 Arif Bilal Chief Tech Ops Officer Other disposed transaction
F
Common Stock 3,682 $80.34 $295,812 22,886
2023-11-17 Rodino-Klapac Louise Head of R&D, CSO Other disposed transaction
F
Common Stock 4,508 $82.98 $374,074 65,751
2023-11-03 Barry Richard Dir Open-market buy
P
Common Stock 40,000 $78.81 $3,152,400 140,000
2023-11-03 Barry Richard Dir Open-market buy
P
Common Stock 10,000 $78.81 $788,100 10,000
2023-08-14 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 4,032 $109.89 $443,076 246,996
2023-08-14 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 5,947 $109.19 $649,353 242,964
2023-08-11 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 23,686 $108.05 $2,559,272 237,017
2023-08-10 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 31,570 $106.26 $3,354,628 213,331
2023-08-10 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 1,091 $105.90 $115,537 181,761
2023-08-10 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 2,206 $104.67 $230,902 180,670
2023-08-04 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 15,000 $0.00 $0 0
2023-08-04 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 15,000 $106.72 $1,600,800 20,994
2023-08-04 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 15,000 $29.03 $435,450 35,994
2023-06-01 Brown Ryan Edward EVP, General Counsel Other disposed transaction
F
Common Stock 89 $123.60 $11,000 28,096
2023-03-30 Arif Bilal Chief Tech Ops Officer Other disposed transaction
F
Common Stock 307 $136.66 $41,955 26,367
2023-03-08 Rodino-Klapac Louise Head of R&D, CSO Other disposed transaction
F
Common Stock 912 $153.19 $139,709 70,170
2023-03-06 Wigzell Hans Lennart Rudolf Dir Equity grant / award
A · derivative
Stock Option (right to buy) 3,257 $0.00 $0 3,257
2023-03-06 Wigzell Hans Lennart Rudolf Dir Equity grant / award
A
Common Stock 1,523 $0.00 $0 20,994
2023-03-01 Arif Bilal Chief Tech Ops Officer Other disposed transaction
F
Common Stock 172 $147.57 $25,382 22,828
2023-03-01 Arif Bilal Chief Tech Ops Officer Other disposed transaction
F
Common Stock 80 $147.57 $11,806 22,837
2022-12-31 Arif Bilal Chief Tech Ops Officer Equity grant / award
A · derivative
Stock Option (right to buy) 30,000 $0.00 $0 30,000
2022-12-19 BEHRENS M KATHLEEN Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 20,000 $0.00 $0 0
2022-12-19 BEHRENS M KATHLEEN Dir Exercise / conversion
M
Common Stock 20,000 $34.92 $698,400 158,470
2022-11-17 Rodino-Klapac Louise Head of R&D, CSO Other disposed transaction
F
Common Stock 4,211 $108.52 $456,978 67,998
2022-09-14 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 6,250 $105.16 $657,250 108,178
2022-09-14 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 30,106 $104.67 $3,151,195 101,928
2022-09-14 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 20,744 $103.87 $2,154,679 71,822
2022-09-13 Chambers Michael Andrew Dir Equity grant / award
A · derivative
Convertible Senior Notes $20,000,000.00
2022-08-19 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 6,060 $108.80 $659,328 51,078
2022-08-19 Chambers Michael Andrew Dir Open-market buy
P
Common Stock 40,110 $108.20 $4,339,902 45,018
2022-06-02 Boor Kathryn Jean Dir Equity grant / award
A · derivative
Stock Option (right to buy) 8,329 $0.00 $0 8,329
2022-06-02 Boor Kathryn Jean Dir Equity grant / award
A
Common Stock 4,908 $0.00 $0 4,908
2022-06-01 Brown Ryan Edward SVP, General Counsel Other disposed transaction
F
Common Stock 54 $72.67 $3,924 25,841
2022-03-07 Estepan Ian Michael Chief Financial Officer Equity grant / award
A · derivative
Stock Option (right to sell) 48,000 $0.00 $0 48,000
2022-03-07 Estepan Ian Michael Chief Financial Officer Equity grant / award
A
Common Stock 8,000 $0.00 $0 32,671
2022-03-07 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 398 $79.36 $31,585 24,671
2022-03-07 Mayo Stephen Dir Equity grant / award
A · derivative
Stock Option (right to buy) 5,077 $0.00 $0 5,077
2022-03-07 Mayo Stephen Dir Equity grant / award
A
Common Stock 2,953 $0.00 $0 7,245
2022-03-04 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 1,308 $79.20 $103,594 25,069
2022-03-01 Rodino-Klapac Louise Head of R&D, CSO Other disposed transaction
F
Common Stock 572 $75.05 $42,929 65,327
2021-12-15 BEHRENS M KATHLEEN Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 5,000 $0.00 $0 0
2021-12-15 BEHRENS M KATHLEEN Dir Exercise / conversion
M
Common Stock 5,000 $10.08 $50,400 135,517
2021-12-10 GRAY MARY ANN Dir Exercise / conversion
M · derivative
Restricted Stock Units 967 $0.00 $0 0
2021-12-10 GRAY MARY ANN Dir Exercise / conversion
M
Common Stock 967 $0.00 $0 9,403
2021-11-24 Rodino-Klapac Louise Head of R&D, CSO Open-market buy
P
Common Stock 3,780 $79.33 $299,867 65,678
2021-11-17 INGRAM DOUGLAS S President & CEO Open-market buy
P
Common Stock 25,026 $79.94 $2,000,578 365,082
2021-11-16 Mayo Stephen Dir Equity grant / award
A · derivative
Stock Option (right to buy) 8,238 $0.00 $0 8,238
2021-11-16 Mayo Stephen Dir Equity grant / award
A
Common Stock 4,292 $0.00 $0 4,292
2021-09-08 Estepan Ian Michael Chief Financial Officer Other disposed transaction
F
Common Stock 1,623 $78.29 $127,065 26,753
2021-06-26 INGRAM DOUGLAS S President & CEO Other disposed transaction
F
Common Stock 17,812 $80.40 $1,432,085 340,056
2021-06-01 Brown Ryan Edward SVP, General Counsel Other disposed transaction
F
Common Stock 64 $76.01 $4,865 19,368
2021-03-10 BEHRENS M KATHLEEN Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 5,000 $0.00 $0 0
2021-03-10 BEHRENS M KATHLEEN Dir Open-market sell
S
Common Stock 5,000 $85.76 $428,800 130,517
2021-03-10 BEHRENS M KATHLEEN Dir Exercise / conversion
M
Common Stock 5,000 $42.30 $211,500 135,517
2021-03-08 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 10,000 $0.00 $0 0
2021-03-08 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 10,000 $83.51 $835,100 16,518
2021-03-08 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 10,000 $34.92 $349,200 26,518
2021-03-03 O'Neill Gilmore Neil EVP, R&D & CMO Equity grant / award
A
Common Stock 15,000 $0.00 $0 28,546
2021-03-03 Wigzell Hans Lennart Rudolf Dir Equity grant / award
A · derivative
Stock Option (right to buy) 5,518 $0.00 $0 5,518
2021-03-03 Wigzell Hans Lennart Rudolf Dir Equity grant / award
A
Common Stock 2,726 $0.00 $0 16,518
2021-02-28 O'Neill Gilmore Neil EVP, R&D & CMO Other disposed transaction
F
Common Stock 524 $86.97 $45,572 13,546
2020-12-31 INGRAM DOUGLAS S President & CEO Other disposed transaction
F
Common Stock 37,144 $170.49 $6,332,681 357,868
2020-12-14 Rodino-Klapac Louise Chief Scientific Officer Equity grant / award
A · derivative
Stock Option (right to buy) 25,000 $0.00 $0 25,000
2020-12-11 Bratica Joseph Principal Financial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 1,115 $0.00 $0 12,285
2020-12-11 Bratica Joseph Principal Financial Officer Open-market sell
S
Common Stock 1,115 $165.00 $183,975 8,140
2020-12-11 Bratica Joseph Principal Financial Officer Exercise / conversion
M
Common Stock 1,115 $71.45 $79,667 9,255
2020-12-10 GRAY MARY ANN Dir Exercise / conversion
M · derivative
Restricted Stock Units 967 $0.00 $0 967
2020-12-10 GRAY MARY ANN Dir Exercise / conversion
M
Common Stock 967 $0.00 $0 5,710
2020-12-08 Bratica Joseph Principal Financial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 1,125 $0.00 $0 4,500
2020-12-08 Bratica Joseph Principal Financial Officer Open-market sell
S
Common Stock 1,125 $160.00 $180,000 8,140
2020-12-08 Bratica Joseph Principal Financial Officer Exercise / conversion
M
Common Stock 1,125 $29.60 $33,300 9,265
2020-08-10 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 10,000 $0.00 $0 10,000
2020-08-10 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 777 $159.65 $124,048 13,792
2020-08-10 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 9,223 $158.95 $1,465,996 14,569
2020-08-10 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 10,000 $34.92 $349,200 23,792
2020-08-07 Barry Richard Dir Open-market sell
S
Common Stock 3,140 $159.09 $499,543 3,129,140
2020-08-07 Barry Richard Dir Open-market sell
S
Common Stock 26,860 $158.43 $4,255,430 3,132,280
2020-08-03 Bratica Joseph Principal Financial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 1,125 $0.00 $0 5,625
2020-08-03 Bratica Joseph Principal Financial Officer Open-market sell
S
Common Stock 1,125 $155.00 $174,375 7,832
2020-08-03 Bratica Joseph Principal Financial Officer Exercise / conversion
M
Common Stock 1,125 $29.60 $33,300 8,957
2020-07-08 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 1,203 $32.63 $39,254 0
2020-07-08 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 218 $13.71 $2,989 0
2020-07-08 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 2,385 $13.71 $32,698 0
2020-07-08 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 1,203 $32.63 $39,254 20,260
2020-07-08 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 218 $13.71 $2,989 19,057
2020-07-08 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 2,385 $13.71 $32,698 18,839
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 45,000 $0.00 $0 7,708
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 56,984 $0.00 $0 0
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 1,858 $0.00 $0 0
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 1,280 $0.00 $0 0
2020-06-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 55,270 $171.50 $9,478,805 31,871
2020-06-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 35,757 $170.59 $6,099,787 87,141
2020-06-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 8,086 $169.56 $1,371,062 122,898
2020-06-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 6,009 $168.61 $1,013,177 130,984
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 45,000 $29.03 $1,306,350 136,993
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 56,984 $23.85 $1,359,068 91,993
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 1,858 $13.71 $25,473 35,009
2020-06-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 1,280 $13.71 $17,549 33,151
2020-05-20 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Stock Oprion (right to buy) 5,000 $0.00 $0 0
2020-05-20 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 854 $151.77 $129,612 13,792
2020-05-20 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 2,046 $151.22 $309,396 14,646
2020-05-20 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 2,100 $149.62 $314,202 16,692
2020-05-20 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 5,000 $10.08 $50,400 18,792
2020-05-15 Barry Richard Dir Open-market sell
S
Common Stock 4,673 $142.05 $663,800 3,159,140
2020-05-15 Barry Richard Dir Open-market sell
S
Common Stock 25,327 $141.12 $3,574,146 3,163,813
2020-05-11 Mahatme Sandesh EVP, CFO & CBO Equity grant / award
G
Common Stock 20,425 $0.00 $0 16,454
2020-03-04 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Stock option (right to buy) 5,000 $0.00 $0 0
2020-03-04 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 5,000 $116.89 $584,450 13,792
2020-03-04 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 5,000 $8.46 $42,300 18,792
2020-02-28 GRAY MARY ANN Dir Equity grant / award
A · derivative
Stock option (right to buy) 3,685 $0.00 $0 3,685
2020-02-28 GRAY MARY ANN Dir Equity grant / award
A
Common Stock 2,075 $0.00 $0 4,743
2019-12-31 INGRAM DOUGLAS S President & CEO Other disposed transaction
F
Common Stock 37,185 $129.04 $4,798,352 395,012
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock option (right to buy) 26,084 $0.00 $0 20,881
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock option (right to buy) 3,895 $0.00 $0 0
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock option (right to buy) 2,727 $0.00 $0 1,123
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Open-market sell
S
Common Stock 9,294 $125.50 $1,166,397 1,867
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Open-market sell
S
Common Stock 32,706 $125.50 $4,104,603 11,161
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 26,084 $26.24 $684,444 43,867
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 3,895 $13.71 $53,400 17,783
2019-12-13 Cumbo Alexander EVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 2,727 $13.71 $37,387 13,888
2019-12-10 GRAY MARY ANN Dir Exercise / conversion
M · derivative
Restricted Stock Units 967 $0.00 $0 1,934
2019-12-10 GRAY MARY ANN Dir Exercise / conversion
M
Common Stock 967 2,668
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 7,900 $0.00 $0 5,118
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 5,590 $0.00 $0 0
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 52 $0.00 $0 18
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 2,440 $0.00 $0 2,470
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 8,580 $0.00 $0 18,579
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 4,025 $0.00 $0 1,858
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 5,685 $0.00 $0 1,280
2019-11-22 Howton David T EVP, General Counsel Other disposed transaction
F
Common Stock 2,804 $107.02 $300,084 25,171
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 7,900 $23.85 $188,415 27,975
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 5,590 $13.90 $77,701 20,075
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 52 $13.71 $713 14,485
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 2,440 $13.71 $33,452 14,433
2019-11-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 2,957 $105.00 $310,485 11,993
2019-11-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 3,753 $105.00 $394,065 14,950
2019-11-22 Howton David T EVP, General Counsel Open-market sell
S
Common Stock 18,290 $105.00 $1,920,450 18,703
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 8,580 $13.90 $119,262 36,993
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 4,025 $13.71 $55,183 28,413
2019-11-22 Howton David T EVP, General Counsel Exercise / conversion
M
Common Stock 5,685 $13.71 $77,941 24,388
2019-11-18 Ciambrone William EVP Equity grant / award
A · derivative
Stock option (right to buy) 80,000 $0.00 $0 80,000
2019-09-13 Barry Richard Dir Open-market buy
P
Common Stock 3,309 $87.49 $289,504 3,187,065
2019-09-12 Barry Richard Dir Open-market buy
P
Common Stock 1,691 $87.49 $147,950 3,183,756
2019-09-09 BONNEY MICHAEL W Dir Open-market buy
P
Common Stock 2,000 $86.74 $173,480 7,051
2019-09-06 BEHRENS M KATHLEEN Dir Open-market buy
P
Common Stock 2,500 $87.98 $219,950 125,667
2019-09-05 BEHRENS M KATHLEEN Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 5,000 $0.00 $0 0
2019-09-05 BEHRENS M KATHLEEN Dir Exercise / conversion
M
Common Stock 5,000 $7.80 $39,000 123,167
2019-08-22 Mahatme Sandesh EVP, CFO & CBO Equity grant / award
G
Common Stock 42,535 $0.00 $0 30,179
2019-08-21 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Appreciation Right 100,000 $0.00 $0 0
2019-08-21 Mahatme Sandesh EVP, CFO & CBO Other disposed transaction
F
Common Stock 57,465 $101.50 $5,832,698 72,714
2019-08-21 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 100,000 $23.85 $2,385,000 130,179
2019-08-20 Barry Richard Dir Open-market buy
P
Common Stock 5,000 $99.32 $496,592 3,182,065
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 260 $0.00 $0 218
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 985 $0.00 $0 2,385
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 2,625 $0.00 $0 0
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 3,021 $0.00 $0 0
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 2,863 $0.00 $0 0
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 260 $13.71 $3,565 30,179
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 985 $13.71 $13,504 29,919
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 2,625 $13.90 $36,488 28,934
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 3,021 $29.03 $87,700 26,309
2019-08-15 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 2,863 $34.92 $99,976 23,288
2019-08-14 Barry Richard Dir Open-market buy
P
Common Stock 3,700 $122.50 $453,250 3,177,065
2019-08-12 Barry Richard Dir Open-market buy
P
Common Stock 1,300 $122.50 $159,250 3,173,365
2019-05-24 O'Neill Gilmore Neil EVP, R&D & CMO Other disposed transaction
F
Common Stock 4,630 $119.31 $552,405 7,370
2019-05-23 O'Neill Gilmore Neil EVP, R&D & CMO Exercise / conversion
M · derivative
Restricted Stock Units 12,000 $0.00 $0 0
2019-05-23 O'Neill Gilmore Neil EVP, R&D & CMO Exercise / conversion
M
Common Stock 12,000 12,000
2019-03-28 Mahatme Sandesh EVP, CFO & CBO Other disposed transaction
F
Common Stock 2,953 $118.68 $350,462 20,425
2019-03-28 Mahatme Sandesh EVP, CFO & CBO Equity grant / award
A
Common Stock 6,649 $0.00 $0 23,378
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 43 $0.00 $0 478
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 164 $0.00 $0 3,370
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 3,511 $0.00 $0 2,625
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock option (right to buy) 11,768 $0.00 $0 0
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Other disposed transaction
F
Common Stock 2,625 $126.47 $331,984 16,729
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 43 $13.71 $590 19,354
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 164 $13.71 $2,248 19,311
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 3,511 $13.90 $48,803 19,147
2019-03-19 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 11,768 $23.85 $280,667 15,636
2019-03-04 Mahatme Sandesh EVP, CFO & CBO Equity grant / award
A · derivative
Stock option (right to buy) 55,000 $0.00 $0 55,000
2019-03-04 O'Neill Gilmore Neil EVP, R&D & CMO Equity grant / award
A · derivative
Stock option (right to buy) 55,000 $0.00 $0 55,000
2019-02-28 Mahatme Sandesh EVP, CFO & CBO Other disposed transaction
D
Common Stock 4,781 $0.00 $0 3,868
2019-02-07 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 65,000 $0.00 $0 10,466
2019-02-07 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 65,000 $145.00 $9,425,000 8,649
2019-02-07 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 65,000 $23.85 $1,550,250 73,649
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 5,250 $0.00 $0 46,965
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock Option (right to buy) 2,250 $0.00 $0 0
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Open-market sell
S
Common Stock 15,000 $140.00 $2,100,000 15,266
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 5,250 $26.24 $137,760 30,266
2019-02-01 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 2,250 $13.90 $31,275 25,016
2019-01-31 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 21,198 $0.00 $0 75,466
2019-01-31 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 21,198 $130.72 $2,771,003 8,649
2019-01-31 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 21,198 $23.85 $505,572 29,847
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 19,345 $0.00 $0 96,664
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 17,860 $0.00 $0 0
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 1,128 $0.00 $0 6,771
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 5,469 $0.00 $0 7,404
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 43,802 $130.00 $5,694,260 8,649
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 19,345 $23.85 $461,378 52,451
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 17,860 $13.90 $248,254 33,106
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 1,128 $13.71 $15,465 15,246
2019-01-30 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 5,469 $13.71 $74,980 14,118
2018-12-10 GRAY MARY ANN Dir Equity grant / award
A · derivative
Restricted Stock Units 2,901 $0.00 $0 2,901
2018-12-10 GRAY MARY ANN Dir Equity grant / award
A · derivative
Option (right to buy) 5,711 $0.00 $0 5,711
2018-11-01 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 6,667 $0.00 $0 0
2018-11-01 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 6,667 $140.50 $936,714 10,084
2018-11-01 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 6,667 $8.94 $59,603 16,751
2018-10-31 BEHRENS M KATHLEEN Dir Exercise / conversion
M · derivative
Stock Option (right to buy) 10,000 $0.00 $0 0
2018-10-31 BEHRENS M KATHLEEN Dir Open-market sell
S
Common Stock 10,000 $131.71 $1,317,100 116,534
2018-10-31 BEHRENS M KATHLEEN Dir Exercise / conversion
M
Common Stock 10,000 $3.96 $39,600 126,534
2018-10-30 INGRAM DOUGLAS S President & CEO Open-market buy
P
Common Stock 3,134 $120.94 $379,026 415,945
2018-10-30 INGRAM DOUGLAS S President & CEO Open-market buy
P
Common Stock 13,561 $120.26 $1,630,846 412,811
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 11,718 $0.00 $0 12,873
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 29,080 $0.00 $0 7,899
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 39,006 $0.00 $0 17,860
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Stock Option (right to buy) 9,596 $0.00 $0 116,009
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Equity grant / award
G
Common Stock 12,012 $0.00 $0 12,012
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 107,524 $127.74 $13,735,116 20,661
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 11,718 $13.71 $160,654 128,185
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 29,080 $13.71 $398,687 116,467
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 39,006 $13.90 $542,183 87,387
2018-10-24 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 9,596 $23.85 $228,865 48,381
2018-08-15 INGRAM DOUGLAS S President & CEO Open-market buy
P
Common Stock 16,000 $125.26 $2,004,211 399,250
2018-08-08 Cumbo Alexander SVP, Chief Commercial Officer Other disposed transaction
F
Common Stock 6,000 $121.02 $726,120 22,766
2018-07-16 Howton David T SVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 37,848 $13.90 $526,087 27,159
2018-07-16 Howton David T SVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 9,056 $13.71 $124,158 10,090
2018-07-16 Howton David T SVP, General Counsel Exercise / conversion
M · derivative
Stock option (right to buy) 3,096 $13.71 $42,446 7,431
2018-07-16 Howton David T SVP, General Counsel Open-market sell
S
Common Stock 37,848 $136.46 $5,164,738 34,871
2018-07-16 Howton David T SVP, General Counsel Exercise / conversion
M
Common Stock 37,848 $13.90 $526,087 72,719
2018-07-16 Howton David T SVP, General Counsel Open-market sell
S
Common Stock 9,056 $136.46 $1,235,782 34,871
2018-07-16 Howton David T SVP, General Counsel Exercise / conversion
M
Common Stock 9,056 $13.71 $124,158 43,927
2018-07-16 Howton David T SVP, General Counsel Open-market sell
S
Common Stock 3,096 $136.46 $422,480 34,871
2018-07-16 Howton David T SVP, General Counsel Exercise / conversion
M
Common Stock 3,096 $13.71 $42,446 37,967
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock option (right to buy) 11,914 $13.90 $165,605 2,250
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock option (right to buy) 9,944 $13.71 $136,332 3,895
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock option (right to buy) 11,924 $13.71 $163,478 3,850
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Open-market sell
S
Common Stock 11,914 $137.32 $1,636,030 28,766
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 11,914 $13.90 $165,605 40,680
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Open-market sell
S
Common Stock 9,944 $137.32 $1,365,510 28,766
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 9,944 $13.71 $136,332 38,710
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Open-market sell
S
Common Stock 11,924 $137.32 $1,637,404 28,766
2018-07-09 Cumbo Alexander SVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 11,924 $13.71 $163,478 40,690
2018-06-27 Barry Richard Dir Open-market sell
S
Common Stock 75,000 $130.34 $9,775,500 3,170,432
2018-06-26 INGRAM DOUGLAS S President & CEO Other disposed transaction
F
Common Stock 36,946 $135.53 $5,007,291 383,250
2018-06-07 O'Neill Gilmore Neil SVP & Chief Medical Officer Equity grant / award
A · derivative
Restricted Stock Units 12,000 $0.00 $0 12,000
2018-06-07 O'Neill Gilmore Neil SVP & Chief Medical Officer Equity grant / award
A · derivative
Stock option (right to buy) 100,000 $0.00 $0 100,000
2018-05-22 Ruff Shamim SVP, Chief Regulatory Affairs Exercise / conversion
M · derivative
Restricted Stock Units 4,432 $0.00 $0 0
2018-05-22 Ruff Shamim SVP, Chief Regulatory Affairs Other disposed transaction
F
Common Stock 1,305 $89.22 $116,432 31,936
2018-05-22 Ruff Shamim SVP, Chief Regulatory Affairs Exercise / conversion
M
Common Stock 4,432 33,241
2018-03-15 Ruff Shamim SVP, Chief Regulatory Affairs Exercise / conversion
M · derivative
Stock option (right to buy) 2,031 $0.00 $0 10,066
2018-03-15 Ruff Shamim SVP, Chief Regulatory Affairs Exercise / conversion
M · derivative
Stock option (right to buy) 469 $0.00 $0 6,134
2018-03-15 Ruff Shamim SVP, Chief Regulatory Affairs Other disposed transaction
F
Common Stock 656 $81.22 $53,280 28,809
2018-03-15 Ruff Shamim SVP, Chief Regulatory Affairs Exercise / conversion
M
Common Stock 2,031 $26.24 $53,293 29,465
2018-03-15 Ruff Shamim SVP, Chief Regulatory Affairs Other disposed transaction
F
Common Stock 80 $81.22 $6,498 27,434
2018-03-15 Ruff Shamim SVP, Chief Regulatory Affairs Exercise / conversion
M
Common Stock 469 $13.90 $6,519 27,514
2018-03-05 Wigzell Hans Lennart Rudolf Dir Equity grant / award
A · derivative
Stock option (right to buy) 4,820 $0.00 $0 4,820
2018-03-05 Wigzell Hans Lennart Rudolf Dir Equity grant / award
A
Common Stock 3,418 $0.00 $0 10,084
2017-12-04 BONNEY MICHAEL W Dir Equity grant / award
A · derivative
Non-Qualified Stock Options (right to buy) 16,400 $0.00 $0 16,400
2017-11-30 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 6,667 $7.38 $49,202 0
2017-11-30 Wigzell Hans Lennart Rudolf Dir Open-market sell
S
Common Stock 6,667 $55.89 $372,619 6,666
2017-11-30 Wigzell Hans Lennart Rudolf Dir Exercise / conversion
M
Common Stock 6,667 $7.38 $49,202 13,333
2017-11-08 INGRAM DOUGLAS S President & CEO Open-market buy
P
Common Stock 38,138 $52.44 $1,999,957 420,196
2017-11-06 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 10,000 $14.76 $147,600 31,144
2017-11-06 Ruff Shamim SVP, Regulatory Affairs & Qual Open-market sell
S
Common Stock 10,000 $55.00 $550,000 27,045
2017-11-06 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M
Common Stock 10,000 $14.76 $147,600 37,045
2017-10-03 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 11,500 $14.76 $169,740 41,144
2017-10-03 Ruff Shamim SVP, Regulatory Affairs & Qual Open-market sell
S
Common Stock 11,500 $50.00 $575,000 27,045
2017-10-03 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M
Common Stock 11,500 $14.76 $169,740 38,545
2017-09-25 Basi Guriqbal S. SVP, Chief Scientific Officer Equity grant / award
A · derivative
Stock Option (right to buy) 100,000 $0.00 $0 100,000
2017-08-03 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M · derivative
Restricted Stock Units 8,865 $0.00 $0 0
2017-08-03 Ruff Shamim SVP, Regulatory Affairs & Qual Other disposed transaction
F
Common Stock 2,882 $37.88 $109,170 27,045
2017-08-03 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M
Common Stock 8,865 29,927
2017-07-27 INGRAM DOUGLAS S President & CEO Open-market buy
P
Common Stock 47,058 $42.50 $1,999,965 382,058
2017-07-21 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Incentive Stock Option (right to buy) 1,500 $23.85 $35,775 14,268
2017-07-21 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 1,500 $23.85 $35,775 33,861
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 7,627 $23.85 $181,904 125,605
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 32,998 $13.90 $458,672 56,866
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 9,375 $13.71 $128,531 24,591
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 7,627 $41.00 $312,707 32,361
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 7,627 $23.85 $181,904 39,988
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 32,998 $41.00 $1,352,918 32,361
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 32,998 $13.90 $458,672 65,359
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Open-market sell
S
Common Stock 9,375 $41.00 $384,375 32,361
2017-07-20 Mahatme Sandesh EVP, CFO & CBO Exercise / conversion
M
Common Stock 9,375 $13.71 $128,531 41,736
2017-06-26 INGRAM DOUGLAS S President & CEO Equity grant / award
A · derivative
Stock Option (right to buy) 3,300,000 $0.00 $0 3,300,000
2017-06-26 INGRAM DOUGLAS S President & CEO Equity grant / award
A
Common Stock 335,000 $0.00 $0 335,000
2017-05-19 Cumbo Alexander SVP, Chief Commercial Officer Equity grant / award
A · derivative
Stock Option (right to buy) 40,000 $0.00 $0 40,000
2017-04-20 Kaye Edward M. MD President & CEO Other disposed transaction
F
Common Stock 4,349 $32.54 $141,516 66,820
2017-04-03 Stehman-Breen Catherine SVP, Chief Medical Officer Equity grant / award
A · derivative
Stock Option (right to buy) 100,000 $0.00 $0 100,000
2017-03-19 Howton David T SVP, General Counsel Other disposed transaction
F
Common Stock 152 $30.30 $4,606 22,301
2017-03-10 Cumbo Alexander VP, Head of Commercial Equity grant / award
A · derivative
Incentive Stock Option (right to buy) 4,924 $0.00 $0 4,924
2017-03-10 Cumbo Alexander VP, Head of Commercial Equity grant / award
A · derivative
Non-Qualified Stock Option (right to buy) 22,576 $0.00 $0 22,576
2017-01-20 Kaye Edward M. MD President, CEO & CMO Other disposed transaction
F
Common Stock 4,466 $32.66 $145,860 71,169
2016-11-09 Howton David T SVP, General Counsel Exercise / conversion
M · derivative
Incentive Stock Option (right to buy) 1,000 $0.00 $0 15,768
2016-11-09 Howton David T SVP, General Counsel Exercise / conversion
M
Common Stock 1,000 $23.85 $23,850 22,453
2016-11-08 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M · derivative
Incentive Stock Option (right to buy) 1,000 $0.00 $0 12,097
2016-11-08 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M
Common Stock 1,000 $26.24 $26,240 21,239
2016-10-20 Kaye Edward M. MD President, CEO & CMO Other disposed transaction
F
Common Stock 4,348 $49.05 $213,269 72,635
2016-10-17 Mahatme Sandesh Senior Vice President, CFO Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 30,000 $13.90 $417,000 19,874
2016-10-17 Mahatme Sandesh Senior Vice President, CFO Open-market sell
S
Common Stock 30,000 $50.08 $1,502,502 31,532
2016-10-17 Mahatme Sandesh Senior Vice President, CFO Exercise / conversion
M
Common Stock 30,000 $13.90 $417,000 61,532
2016-09-22 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 7,311 $13.90 $101,623 8,486
2016-09-22 Ruff Shamim SVP, Regulatory Affairs & Qual Open-market sell
S
Common Stock 7,311 $60.00 $438,660 20,239
2016-09-22 Ruff Shamim SVP, Regulatory Affairs & Qual Exercise / conversion
M
Common Stock 7,311 $13.90 $101,623 27,550
2016-09-19 Aphale Jayant VP, Technical Operations Exercise / conversion
M · derivative
Incentive Stock Options (right to buy) 25,000 $4.62 $115,500 61,580
2016-09-19 Aphale Jayant VP, Technical Operations Exercise / conversion
M · derivative
Non-Qualified Stock Options (right to buy) 10,000 $4.62 $46,200 3,420
2016-09-19 Aphale Jayant VP, Technical Operations Open-market sell
S
Common Stock 25,000 $50.00 $1,250,000 11,490
2016-09-19 Aphale Jayant VP, Technical Operations Exercise / conversion
M
Common Stock 25,000 $4.62 $115,500 36,490
2016-09-19 Aphale Jayant VP, Technical Operations Open-market sell
S
Common Stock 10,000 $50.00 $500,000 11,490
2016-09-19 Aphale Jayant VP, Technical Operations Exercise / conversion
M
Common Stock 10,000 $4.62 $46,200 21,490
2016-09-14 Kaye Edward M. MD SVP Interim CEO & CMO Open-market sell
S
Common Stock 24,557 $30.00 $736,710 76,983
2016-08-31 Kaye Edward M. MD SVP Interim CEO & CMO Other disposed transaction
F
Common Stock 1,487 $26.07 $38,766 101,540
2016-07-20 Kaye Edward M. MD SVP Interim CEO & CMO Other disposed transaction
F
Common Stock 3,001 $22.46 $67,402 103,027
2016-04-20 Kaye Edward M. MD SVP Interim CEO & CMO Other disposed transaction
F
Common Stock 3,001 $19.71 $59,150 106,028

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
21
Material Event Filings (8-K) — 12 months
12

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.